Rigel Pharmaceuticals Inc (NAS:RIGL)
$ 16.5 -0.76 (-4.4%) Market Cap: 304.04 Mil Enterprise Value: 303.15 Mil PE Ratio: 75.04 PB Ratio: 0 GF Score: 77/100

Rigel Pharmaceuticals Inc Annual Shareholders Meeting Transcript

May 14, 2020 / 01:00PM GMT
Release Date Price: $17.5 (-3.31%)
Operator

Ladies and gentlemen, thank you for standing by. And welcome to the Rigel Pharmaceuticals Annual Meeting of Stockholders. It's now my pleasure to hand the conference over to Raul Rodriguez, President and Chief Executive Officer. Raul?

Raul R. Rodriguez
Rigel Pharmaceuticals, Inc. - President, CEO & Director

Good morning. I am Raul Rodriguez, I am the President and Chief Executive Officer and a member of the Board of Directors of Rigel Pharmaceuticals. I'm very happy to welcome you to the Rigel Pharmaceuticals 2020 Annual Meeting of Stockholders.

As you know, we are hosting today's meeting through a virtual online platform hosted by Broadridge Financial Solutions. Stockholders who are attending this meeting with a valid 16-digit control number will have the opportunity to submit questions or comments during the Q&A portion of this meeting through the text box located on your screen. We will try to answer any questions -- any such questions submitted that are germane to the proposals and/or this meeting and if they were -- and if we have time.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot